Related Experiment Video
Updated: Nov 8, 2025

08:20
In Vitro Model of Human Cutaneous Hypertrophic Scarring using Macromolecular Crowding
Published on: May 1, 2020
6.9K
[Expression and effect of microRNA-627 in human hypertrophic scar]
1Department of Burns and Plastic Surgery, General Hospital of Northern Theater Command, Shenyang 110016, China.
Summary
MicroRNA-627 (miR-627) is downregulated in human hypertrophic scars. Increasing miR-627 inhibits fibroblast proliferation and promotes apoptosis by targeting insulin-like growth factor I (IGF-I).
Area of Science:
- Molecular Biology
- Dermatology
- Biochemistry
Background:
- Hypertrophic scars result from dysregulated fibroblast activity.
- MicroRNAs play crucial roles in cellular processes and disease development.
Purpose of the Study:
- To investigate the expression of microRNA-627 (miR-627) in human hypertrophic scars.
- To determine the effect of miR-627 on fibroblast proliferation, apoptosis, and related protein expression.
Main Methods:
- Real-time quantitative PCR to measure miR-627 mRNA expression in scar and normal tissues.
- In vitro experiments using human hypertrophic scar fibroblasts (Fbs) transfected with miR-627 mimics or inhibitors.
- Assays for cell viability, apoptosis, and protein expression (IGF-I, collagen I, α-SMA) via Western blotting and flow cytometry.
- Luciferase reporter assays to confirm the targeting of IGF-I by miR-627.
Main Results:
- miR-627 expression was significantly lower in hypertrophic scar tissue compared to normal skin.
- Upregulation of miR-627 reduced Fb viability and increased apoptosis, while inhibition had opposite effects.
- miR-627 mimic transfection decreased the expression of IGF-I, collagen I, and α-SMA.
- Luciferase assays confirmed that miR-627 directly targets IGF-I, and this targeting was abolished by IGF-I mutation.
Conclusions:
- miR-627 expression is downregulated in human hypertrophic scars.
- miR-627 inhibits fibroblast proliferation and promotes apoptosis.
- The mechanism involves the targeted inhibition of insulin-like growth factor I (IGF-I) expression.
Related Concept Videos
MicroRNAs
3.3K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.3K
MicroRNAs
22.8K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
22.8K
Clinical Applications of Epidermal Stem Cells
3.0K
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
3.0K

